A citation-based method for searching scientific literature

Ilana Cass, Rae Lynn Baldwin, Taz Varkey, Roxana Moslehi, Steven A Narod, Beth Y Karlan. Cancer 2003
Times Cited: 340



Qian Zhong, Hong-Ling Peng, Xia Zhao, Lin Zhang, Wei-Ting Hwang. Clin Cancer Res 2015
Times Cited: 102




List of shared articles



Times cited

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Mary B Daly, Tuya Pal, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Michael Goggins, Mollie L Hutton,[...]. J Natl Compr Canc Netw 2021
34

Epithelial ovarian cancer risk: A review of the current genetic landscape.
Nicola Flaum, Emma J Crosbie, Richard J Edmondson, Miriam J Smith, Dafydd G Evans. Clin Genet 2020
9

Efficacy and safety of PARP inhibitors as the maintenance therapy in ovarian cancer: a meta-analysis of nine randomized controlled trials.
Fengping Shao, Jun Liu, Yaoyun Duan, Li Li, Liqun Liu, Cai Zhang, Shanyang He. Biosci Rep 2020
7

Five-year survival decreases over time in patients with BRCA-mutated ovarian cancer: a systemic review and meta-analysis.
Chen Nahshon, Ofra Barnett-Griness, Yakir Segev, Meirav Schmidt, Ludmila Ostrovsky, Ofer Lavie. Int J Gynecol Cancer 2020
1

BRCA1, Ki67, and β-Catenin Immunoexpression Is Not Related to Differentiation, Platinum Response, or Prognosis in Women With Low- and High-Grade Serous Ovarian Carcinoma.
Luis Felipe Sallum, Liliana Andrade, Larissa Bastos Eloy da Costa, Susana Ramalho, Amanda Canato Ferracini, Rodrigo de Andrade Natal, Angelo Borsarelli Carvalho Brito, Luis Otávio Sarian, Sophie Derchain. Int J Gynecol Cancer 2018
4




Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status.
Joanne Kotsopoulos, Barry Rosen, Isabel Fan, Joel Moody, John R McLaughlin, Harvey Risch, Taymaa May, Ping Sun, Steven A Narod. Gynecol Oncol 2016
54

Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis.
Renaud Sabatier, Elise Lavit, Jessica Moretta, Eric Lambaudie, Tetsuro Noguchi, François Eisinger, Elisabeth Cherau, Magali Provansal, Doriane Livon, Laetitia Rabayrol,[...]. Fam Cancer 2016
4

Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival.
Nicoletta Biglia, Paola Sgandurra, Valentina Elisabetta Bounous, Furio Maggiorotto, Eleonora Piva, Emanuele Pivetta, Riccardo Ponzone, Barbara Pasini. Ecancermedicalscience 2016
18

BRCA mutations and survival in breast cancer: an updated systematic review and meta-analysis.
Yaning Zhu, Jian Wu, Chengwan Zhang, Suan Sun, Jian Zhang, Wenjie Liu, Jian Huang, Zhihong Zhang. Oncotarget 2016
24